Renin-angiotensin-aldosterone system blockade in diabetic nephropathy. present evidences

HIGHLIGHTS

  • who: Luz Lozano-Maneiro and Adriana Puente-García from the Division of Nephrology, Department of Internal Medicine, Fuenlabrada University Hospital have published the research: Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences, in the Journal: (JOURNAL)
  • what: The post hoc analysis of this trial showed that the risk of cardiovascular deaths for systolic blood pressure (SBP) less than 120 mmHg and DBP less than 85 mmHg was increased because of the high risk of all-cause mortality and myocardial infarction .  They conclude "…the results of the study show that the use of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?